Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About Wellness Center USA, Inc.
Wellness Center USA, Inc. engages in the provision of healthcare and medical business. The company is headquartered in Hoffman Estates, Illinois. The company went IPO on 2012-02-08. The Company’s segments include Medical Devices and Authentication and Encryption Products and Services. The segments are operated through Psoria-Shield Inc. (PSI) and StealthCo Inc. (SCI). PSI designs, develops, and markets a targeted UV phototherapy device called the Psoria-Light. The Psoria-Light is designated for use in targeted PUVA photochemistry and UVB phototherapy and is designed to treat certain skin conditions, including psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma. SCI is a provider of Stealth Mark encryption and authentication solutions offering advanced technologies within the security and supply chain management vertical sectors (Intelligent Microparticles), and advanced data intelligence services offering technology for industries, companies, and agencies on a global scale (ActiveDuty).
Industry: Pharmaceutical Preparations Peers: ABBOTT LABORATORIES Advanced Biomedical Technologies Inc. Bionik Laboratories Corp. ThermoGenesis Holdings, Inc. CYduct Diagnostics, Inc. INVIVO THERAPEUTICS HOLDINGS CORP. ECGI Holdings, Inc.
